Scientific and Medical Equipment House Company (4014) fair value: what the stock is really worth
We calculate from audited financials what Scientific and Medical Equipment House Company is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch Scientific and Medical Equipment House Company for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
54‑month range 26.12 SAR – 57.56 SAR · fair‑value band 9.46 SAR – 17.91 SAR · the 27.40 SAR price screens above the 14.33 SAR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.
Scientific and Medical Equipment House Company provides technological solutions and services for healthcare and catering projects in the Kingdom of Saudi Arabia.
Show more
Scientific and Medical Equipment House Company provides technological solutions and services for healthcare and catering projects in the Kingdom of Saudi Arabia. It operates through operation and Maintenance, Medical Equipment Sales and Post-Sale Maintenance Services Revenue, Construction, Meat and Food, and Medicine and Medical Supplies segments.It engages in the supply of medical and nonmedical staff; general contracting of buildings, roads, bridges, dams, electrical, electronic, and mechanical works; operation of restaurants and hospitals; maintenance and operation of industrial, water, and sewage works; maintenance of scientific and medical equipment; sale of safety equipment; installation and maintenance of firefighting and fire alarm equipment, lighting systems and equipment, cooling, air conditioning, electric, gas, and oil heating systems; filling and maintenance of fire extinguishers; sale, installation, and maintenance of security surveillance cameras, security detectors, inspection, and burglar alarm devices; and manufacture of radiological equipment, tubes, and devices. It is also involved in the repair and maintenance of radiological, electronic, medical and therapeutic equipment; export, wholesale, and retail trade in medical, electronical, electrical, and mechanical equipment and devices, laundries, incinerator equipment, and pumps; manufacture of pacemakers and ECG devices; installation and extension of television, satellite, computer, telecommunications networks, Installation and maintenance of fire alarm, security systems and equipment, and electrical and communication wires; and wholesale of food and drinks. In addition, it provides catering and private civil security guard services, cleaning services, building maintenance and land freight services, and refrigerated food warehouse services, as well as meat, frozen vegetables, and dry food. The company was incorporated in 1979 and is based in Riyadh, the Kingdom of Saudi Arabia.
Stock analysis
Scientific and Medical Equipment House Company (4014) currently trades at 27.40 SAR, while our model-based Fair Value estimate is 14.33 SAR, implying the stock looks roughly 91.2% overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 18.25 SAR per share, and 0 of the 17 models we run sit above the 27.40 SAR price.
Bear case: the Earnings-Based group reads lowest at 6.04 SAR, and 17 of the 17 models stay below the price. Evidence for this calculation is high.
Scenario range: 9.46 SAR (bear) to 17.91 SAR (bull), the price of 27.40 SAR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Scientific and Medical Equipment House Company reported revenue of 877M SAR in FY2025 versus 699M SAR in FY2021, a compound +5.8%/yr. Reported net income was 28.4M SAR in FY2025, compounding −22.2%/yr from FY2021.
Key figures
Market cap 819M SAR (≈ $218M) · P/E ratio 28.2 · P/S ratio 0.92 · EPS (TTM) 0.9700 SAR · Dividend yield 3.7% · Net margin 3.2% · Return on equity 5.3% · Return on assets (EBIT) 6.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 31% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at −48%, 4014 screens richer than that median.
Fair Value models
Bear 9.46 SARFair Value 14.33 SARBull 17.91 SAR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 8 months old). Earnings retained since then (0.6830 SAR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.33/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−0.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.1%
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−20.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−24.0%
Dividend (yield on the price)3.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 5%
Compare Scientific and Medical Equipment House Company with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 202 stocks
Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score49 · Below median
Fair Value upside−46% · Below median
Profitability
Return on equity (TTM)5% · Below median
Return on assets2% · Below median
Net margin (TTM)3% · Below median
Operating margin (TTM)4% · Below median
Growth and dividend
Revenue growth−13% · Bottom 25%
Dividend yield (TTM)3.7% · Top 25%
Balance sheet
Debt / equity0.01× · Lowest 25%
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
P/E (TTM)28.2× · Pricier than median
P/B0.43× · Cheapest 25%
P/S (TTM)0.26× · Cheapest 25%
EV/EBITDA5.0× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 16
FUTURE (revenue growth)0· sector 24
PAST (return on equity)21· sector 25
HEALTH (low debt)100· sector 96
DIVIDEND (yield)73· sector 32
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Scientific and Medical Equipment House Company Fair Value". https://www.fairvalue-calculator.com/stock/4014
Frequently asked questions
Is Scientific and Medical Equipment House Company (4014) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of 14.33 SAR versus a price of 27.40 SAR, about −48% upside (overvalued).
What is the fair value of 4014?
Our model-based fair value for Scientific and Medical Equipment House Company is 14.33 SAR (as of Sep 13, 2026), built from audited fundamentals. The current price: 27.40 SAR.
What is the quality score of 4014?
Scientific and Medical Equipment House Company has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Scientific and Medical Equipment House Company (4014)?
Our model-based price target is the fair value of 14.33 SAR (as of Sep 13, 2026) from 17 valuation models. Cautious scenario 9.46 SAR, optimistic scenario 17.91 SAR. It is a calculation from audited fundamentals, not an analyst target.
What is the Scientific and Medical Equipment House Company stock forecast for 2026?
Our models put fair value at 14.33 SAR, about −48% upside versus a price of 27.40 SAR (overvalued). Cautious scenario 9.46 SAR, optimistic scenario 17.91 SAR. The calculation is refreshed regularly with new filings.
What is the revenue of Scientific and Medical Equipment House Company (4014)?
Scientific and Medical Equipment House Company reported trailing-twelve-month revenue of about 847M SAR (latest available figure, as of Sep 13, 2026).
Does Scientific and Medical Equipment House Company pay a dividend?
Scientific and Medical Equipment House Company currently shows a dividend yield of about 3.67% relative to its recent price (as of Sep 13, 2026).
What is the intrinsic value of Scientific and Medical Equipment House Company (4014)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Scientific and Medical Equipment House Company it is 14.33 SAR per share (as of Sep 13, 2026), against a price of 27.40 SAR. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Scientific and Medical Equipment House Company stock overvalued or undervalued in 2026?
As of Sep 13, 2026, 4014 trades above its calculated fair value: price 27.40 SAR, fair value 14.33 SAR, a gap of about −48% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4014?
No. The price is what the market pays today (27.40 SAR); the fair value is what the company's own numbers justify (14.33 SAR). For Scientific and Medical Equipment House Company the two are 13.07 SAR per share apart. That gap is exactly why we show both numbers side by side.
How much is Scientific and Medical Equipment House Company worth?
The market values Scientific and Medical Equipment House Company at about 819M SAR (market capitalisation, as of Sep 13, 2026). Per share that is 27.40 SAR; our models calculate a fair value of 14.33 SAR per share.
What do the bullish and bearish scenarios say about 4014?
Our models span a range for Scientific and Medical Equipment House Company: cautious scenario 9.46 SAR, base 14.33 SAR, optimistic 17.91 SAR per share (as of Sep 13, 2026, price 27.40 SAR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 4014?
Scientific and Medical Equipment House Company trades at a price-to-earnings ratio of 28.2 (as of Sep 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 14.33 SAR is built from several models across several years. Other multiples: P/B 0.4, P/S 0.3, EV/EBITDA 5.0.
How solid is the balance sheet of Scientific and Medical Equipment House Company (4014)?
Balance-sheet figures for Scientific and Medical Equipment House Company (as of Sep 13, 2026): return on equity 5.3%, debt of 0.01 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is 4014 from its 52-week high?
Scientific and Medical Equipment House Company trades at 27.40 SAR, about 31% below its 52-week high of 39.69 SAR and 9% above the low of 25.17 SAR (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of 14.33 SAR is for.
Which stocks are comparable to Scientific and Medical Equipment House Company?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Scientific and Medical Equipment House Company stock attractive at the current price?
The data as of Sep 13, 2026: price 27.40 SAR, calculated fair value 14.33 SAR (−48%), Quality Score 49/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4014 calculated?
We run Scientific and Medical Equipment House Company through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 14.33 SAR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Scientific and Medical Equipment House Company itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Scientific and Medical Equipment House Company right now?
The price sits above even our optimistic bull case (17.91 SAR). The favourable scenario is already priced in. Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (9.46 SAR to 17.91 SAR) leaves room in how you read the outcome.
Key figures of Scientific and Medical Equipment House Company
How large is the market capitalisation of Scientific and Medical Equipment House Company (4014)?
The market capitalisation of Scientific and Medical Equipment House Company is 819M SAR (≈ $218M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Scientific and Medical Equipment House Company (4014)?
The price-to-sales ratio of Scientific and Medical Equipment House Company is 0.92 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Scientific and Medical Equipment House Company (4014)?
Earnings per share at Scientific and Medical Equipment House Company are 0.9700 SAR (price ÷ EPS = P/E 28.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Scientific and Medical Equipment House Company (4014)?
The dividend yield of Scientific and Medical Equipment House Company is 3.7% (payout 104%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Scientific and Medical Equipment House Company (4014)?
The net margin of Scientific and Medical Equipment House Company is 3.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Scientific and Medical Equipment House Company (4014)?
The return on equity (ROE) of Scientific and Medical Equipment House Company is 5.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Scientific and Medical Equipment House Company (4014)?
On an EBIT basis the return on assets of Scientific and Medical Equipment House Company is 6.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Scientific and Medical Equipment House Company (4014)?
The operating margin of Scientific and Medical Equipment House Company is 4.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Scientific and Medical Equipment House Company (4014)?
Revenue at Scientific and Medical Equipment House Company is growing −13.4% versus a year earlier (3y avg +7.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Scientific and Medical Equipment House Company (4014)?
Earnings per share at Scientific and Medical Equipment House Company are growing +7.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Scientific and Medical Equipment House Company (4014) generate?
The free cash flow of Scientific and Medical Equipment House Company is −12.8M SAR (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Scientific and Medical Equipment House Company (4014) carry?
The net debt of Scientific and Medical Equipment House Company is 171M SAR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Scientific and Medical Equipment House Company in the live analysis
One click puts Scientific and Medical Equipment House Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
